Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Intra-Cellular Therapies Inc ITCI

Healthcare Psychedelics
Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders. The Company leverages intracellular approach to develop treatments for people living with complex psychiatric and neurologic diseases. The Company’s product, CAPLYTA (lumateperone), is an oral, once daily atypical... see more

Recent & Breaking News (NDAQ:ITCI)

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Intra-Cellular Therapies, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire May 11, 2017

EQUITY ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Intra-Cellular Therapies, Inc. - ITCI

PR Newswire May 11, 2017

Intra-Cellular Therapies Reports First Quarter 2017 Financial Results and Provides Corporate Update

GlobeNewswire May 10, 2017

Intra-Cellular Therapies Presents Data Supporting the Potential for Potent and Rapid Antidepressant Activity with Lumateperone

GlobeNewswire May 8, 2017

Intra-Cellular Therapies To Present at the 19th Annual Conference of the International Society for Bipolar Disorders

GlobeNewswire May 4, 2017

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Intra-Cellular Therapies, Inc. and Advises Investors with Losses to Contact the Firm

Business Wire May 2, 2017

Investor Alert: Kaplan Fox Announces Investigation Of Intra-Cellular Therapies, Inc.

PR Newswire May 2, 2017

INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Intra-Cellular Therapies, Inc.

Business Wire May 2, 2017

How These Biotech Stocks are Faring? -- ContraVir Pharma, Intra-Cellular Therapies, Nivalis Therapeutics, and OncoSec Medical

PR Newswire May 2, 2017

INTRA-CELLULAR INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Intra-Cellular Therapies, Inc. to Contact the Firm

Business Wire May 1, 2017

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Intra-Cellular Therapies, Inc. Limited Investors

Business Wire May 1, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intra-Cellular Therapies, Inc. - ITCI

PR Newswire May 1, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Intra-Cellular Therapies, Inc. (ITCI)

PR Newswire May 1, 2017

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Intra-Cellular Therapies, Inc. – ITCI

Business Wire May 1, 2017

Mid-Morning Market Update: Markets Mostly Higher; DISH Network Profit Tops Estimates

Benzinga.com  May 1, 2017

Intra-Cellular Therapies Provides Corporate Update On Schizophrenia Program

GlobeNewswire May 1, 2017

Biotech Stocks on Investors' Radar -- Editas, Intra-Cellular, Aralez Pharma, and Catabasis Pharma

PR Newswire March 21, 2017

25 Biggest Mid-Day Gainers For Thursday

Benzinga.com  March 2, 2017

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2016 Financial Results and Provides Corporate Update

GlobeNewswire March 1, 2017

Intra-Cellular Therapies to Present at the Cowen and Company 37th Annual Health Care Conference

GlobeNewswire February 28, 2017